BioCryst Pharmaceuticals shares owned by Stonegate Investment Group
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Stonegate Investment Group
from 13F filings
Historical chart of Stonegate Investment Group investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by Stonegate Investment Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioCryst Pharmaceuticals by Stonegate Investment Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $377k | 50k | 7.60 |
| 2024-06-30 | $307k | 50k | 6.18 |
| 2024-03-31 | $252k | 50k | 5.08 |
| 2023-12-31 | $293k | 49k | 5.99 |
| 2023-09-30 | $347k | 49k | 7.08 |
| 2023-06-30 | $345k | 49k | 7.04 |
| 2023-03-31 | $409k | 49k | 8.34 |
| 2022-12-31 | $562k | 49k | 11.48 |
| 2022-09-30 | $617k | 49k | 12.59 |
| 2022-06-30 | $518k | 49k | 10.57 |
| 2022-03-31 | $797k | 49k | 16.27 |
| 2021-12-31 | $678k | 49k | 13.84 |
More positions owned by Stonegate Investment Group
Home Depot (HD)
View all positions for Stonegate Investment Group